Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinomaRenxian Xie, Chuangzhen Chen, Qingxin Cai et al.|Frontiers in Oncology|2024Cited by 14
Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysisRenxian Xie, Chuangzhen Chen, Hongxin Huang et al.|Frontiers in Pharmacology|2023Cited by 10
Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancerJing Li, Li Wan, Huang Haojun et al.|Frontiers in Immunology|2025Cited by 6
A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited settingRenxian Xie, Chuangzhen Chen, Xiaoluan Lin et al.|PLoS ONE|2025Cited by 2
Hippocampus-sparing volume-modulated arc therapy in patients with World Health Organization grade II glioma: a feasibility studyRenxian Xie, Chuangzhen Chen, Hongxin Huang et al.|Frontiers in Oncology|2025Cited by 2